Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in F/m Emerald Life Sciences Innovation ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
F/m Emerald Life Sciences Innovation ETF (LFSC) has returned -4.45% so far this year and 55.83% over the past 12 months.
F/m Emerald Life Sciences Innovation ETF
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Oct 31, 2024, LFSC's average daily return is +0.11%, while the average monthly return is +2.32%. At this rate, your investment would double in approximately 2.5 years.
Historically, 53% of months were positive and 47% were negative. The best month was Nov 2025 with a return of +15.3%, while the worst month was Dec 2024 at -11.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 2 months.
On a daily basis, LFSC closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +7.8%, while the worst single day was Apr 4, 2025 at -6.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.66% | 2.07% | -3.82% | -4.45% | |||||||||
| 2025 | 11.94% | -6.19% | -8.59% | 2.53% | -0.40% | 7.38% | -1.60% | 15.05% | 6.69% | 10.54% | 15.33% | -3.42% | 56.54% |
| 2024 | 5.95% | -11.30% | -6.02% |
Benchmark Metrics
F/m Emerald Life Sciences Innovation ETF has an annualized alpha of 18.10%, beta of 1.08, and R² of 0.41 versus S&P 500 Index. Calculated based on daily prices since November 01, 2024.
- This ETF captured 265.09% of S&P 500 Index gains and 161.39% of its losses — amplifying both gains and losses, but participating more in upside than downside.
- R² of 0.41 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 18.10%
- Beta
- 1.08
- R²
- 0.41
- Upside Capture
- 265.09%
- Downside Capture
- 161.39%
Expense Ratio
LFSC has an expense ratio of 0.54%, placing it in the medium range.
Return for Risk
Risk / Return Rank
LFSC ranks 86 for risk / return — in the top 86% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and compare them to a chosen benchmark (S&P 500 Index).
| LFSC | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.93 | 0.90 | +1.03 |
Sortino ratioReturn per unit of downside risk | 2.65 | 1.39 | +1.26 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.21 | +0.12 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 1.40 | +1.80 |
Martin ratioReturn relative to average drawdown | 8.96 | 6.61 | +2.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore LFSC risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the F/m Emerald Life Sciences Innovation ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the F/m Emerald Life Sciences Innovation ETF was 29.74%, occurring on Apr 8, 2025. Recovery took 94 trading sessions.
The current F/m Emerald Life Sciences Innovation ETF drawdown is 11.08%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -29.74% | Nov 12, 2024 | 100 | Apr 8, 2025 | 94 | Aug 22, 2025 | 194 |
| -16.25% | Dec 11, 2025 | 74 | Mar 30, 2026 | — | — | — |
| -4.92% | Sep 10, 2025 | 5 | Sep 16, 2025 | 2 | Sep 18, 2025 | 7 |
| -4.73% | Nov 3, 2025 | 4 | Nov 6, 2025 | 2 | Nov 10, 2025 | 6 |
| -4.35% | Nov 13, 2025 | 1 | Nov 13, 2025 | 6 | Nov 21, 2025 | 7 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...